Tag: orphan drug designation

September 9, 2019

Adaptimmune Therapeutics Receives Orphan Drug Designation

Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that the US Food and Drug Administration (FDA) has granted it orphan drug designation for...
July 24, 2019

Mustang Bio Receives Orphan Drug Designation for MB-102

Mustang Bio (NASDAQ:MBIO) announced it has received orphan drug designation from the US Food and Drug Administration (FDA) For its...
July 23, 2019

La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118

La Jolla Pharmaceutical (NASDAQ:LJPC) has announced that the US Food and Drug Administration (FDA) has granted the company orphan drug...
June 12, 2019

Catalyst Pharmaceuticals Files Lawsuit Against FDA Over Rival Drug

The company is suing the regulatory agency over the approval of Jacobus Pharmaceutical's rival drug Ruzurgi.
May 28, 2019

Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007

Applied Therapeutics (NASDAQ:APLT) has announced that the US Food and Drug Administration (FDA) has granted the company orphan drug designation...
February 7, 2019

Equillium Granted U.S. FDA Orphan Drug Designations for EQ001

Equillium (NASDAQ:EQ) has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designations for EQ001 for...
January 31, 2019

Prana Granted First MSA Orphan Drug Designation from FDA

Prana revealed Thursday that the FDA has granted it the first orphan drug designation to treat Multiple System Atrophy for...